全球阿立哌唑市场 - 行业趋势及 2029 年预测

市场分析与洞察全球阿立哌唑市场

预计阿立哌唑市场将在 2022-2029 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在上述预测期内，市场复合年增长率将达到 4.60%。

阿立哌唑是一种抗精神病药物，用于治疗成人和 13 岁以上儿童的精神分裂症。阿立哌唑用于治疗成人和 10 岁以上儿童的 I 型双相情感障碍（躁狂抑郁症），可单独使用或与情绪稳定剂联合使用。它与抗抑郁药物联合用于治疗成人重度抑郁症。阿立哌唑口服片剂有品牌药和仿制药两种形式。Abilify、Aristada 和 Abilify Maintena 是品牌药。

全球抑郁症患病率的上升将成为阿立哌唑市场扩张的主要推动力。此外，老年人口的增加、医疗支出的增加以及患有精神分裂症和躁郁症的患者数量的增加都是扩大阿立哌唑市场的因素。生活方式的改变和意识的提高等其他因素将对市场增长率产生积极影响。

此外，研发活动的增加和新兴市场的出现将为 2022-2029 年预测期内的阿立哌唑市场提供有利的机会。

然而，阿立哌唑价格昂贵，且有便秘、头痛、恶心、呕吐、头晕、紧张、胃灼热等副作用。所有这些因素都阻碍了市场的增长。在上述预测期内，缺乏认知度将进一步挑战阿立哌唑市场。

This aripiprazole market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the aripiprazole market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Aripiprazole Market Scope and Market Size

The aripiprazole market is segmented on the basis of drug class, application, demographic, dosage form, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of drug class, the aripiprazole market is segmented into antipsychotics, and antimanic agents.
• On the basis of application, the aripiprazole market is segmented into major depressive disorders, schizophrenia, bipolar mania, and others.
• On the basis of demographic, the aripiprazole market is segmented into adult, and pediatric.
• On the basis of dosage form, the aripiprazole market is segmented into tablets, orally disintegrating tablets, oral solution, and injection. Tablets are further sub-segmented into 2mg, 5mg, 10mg, 15mg, 20mg and 30mg. Orally disintegrating tablets are further sub-segmented into 10mg and 15mg. Oral solution is further sub-segmented into 1mg/ml.
• On the basis of end-users, the aripiprazole market is segmented into clinic, hospital and others.
• The aripiprazole market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Aripiprazole Market Country Level Analysis

Aripiprazole market is analyzed and market size information is provided by the country, drug class, application, demographic, dosage form, end-users and distribution channel as referenced above.

The countries covered in the aripiprazole market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

北美在阿立哌唑市场占据主导地位，因为该地区拥有主要关键参与者、高可支配收入和发达的医疗保健基础设施。由于该地区研发活动不断增加以及政府支持不断增加，预计亚太地区将在 2022-2029 年预测期内实现增长。

报告的国家部分还提供了影响单个市场因素和国内市场法规变化，这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、疾病流行病学和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、销售渠道的影响。

患者流行病学分析

阿立哌唑市场还为您提供详细的市场分析，用于患者分析、预后和治疗。患病率、发病率、死亡率、依从率是报告中提供的一些数据变量。分析流行病学对市场增长的直接或间接影响，以创建更稳健、更队列的多元统计模型，用于预测增长期的市场。

竞争格局和全球阿立哌唑市场份额分析

阿立哌唑市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、公司优势和劣势、产品发布、临床试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对阿立哌唑市场研究的关注有关。

阿立哌唑市场的一些主要参与者包括 Teva Pharmaceutical Industries Ltd.、Aurobindo Pharma、Lannett、Otsuka America Pharmaceutical, Inc.、Alembic Pharmaceuticals Limited、Amneal Pharmaceuticals LLC、Barr Pharmaceuticals、OrchidPharma Ltd.、Apotex Inc.、Accord Healthcare、ANGITA、Alkem Labs、Octavius Pharma Pvt. Ltd.、Interquim, SA de CV.、Polpharma 和 Medinex 等。

SKU-67484